Turnover of domestic pharmaceutical firms up 17%

The 20 major domestic pharmaceutical firms are expected to increase their combined turnover by 17.2 percent this year, according to the 2004 management strategies.

The 20 chief executive officers estimated their combined sales revenue would reach 3.6 trillion won in 2004, up 17.2 percent from last years 3.1 trillion won.

Pharmaceutical business sources say that in a major shift in m...